Casi Pharmaceuticals, INC. (CASIF) SEC Filings — 2025

Filings

• Casi Pharmaceuticals, INC. 6-K Filing — 6-K · Dec 31, 2025
• CASI Pharmaceuticals Files 6-K, Incorporates Exhibits — 6-K · Dec 23, 2025
• Casi Pharmaceuticals, INC. 6-K Filing — 6-K · Dec 11, 2025
• Casi Pharmaceuticals, INC. 6-K Filing — 6-K · Nov 19, 2025
• Casi Pharmaceuticals, INC. 6-K Filing — 6-K · Nov 14, 2025
• CASI Pharmaceuticals Files 6-K Report — 6-K · Nov 10, 2025
• CASI Pharmaceuticals Files 6-K, Incorporates Exhibits — 6-K · Sep 26, 2025
• CASI Pharmaceuticals Files 6-K Report — 6-K · Sep 2, 2025
• CASI Pharmaceuticals Files 6-K, Incorporates Exhibits — 6-K · Aug 29, 2025
• CASI Pharmaceuticals Files 6-K, Incorporates into F-3 Filings — 6-K · Aug 27, 2025
• CASI Pharmaceuticals Files August 2025 Report — 6-K · Aug 4, 2025
• CASI Pharmaceuticals Files 6-K, Incorporates by Reference — 6-K · Jul 22, 2025
• CASI Pharmaceuticals Files 6-K, Incorporates Exhibits — 6-K · May 20, 2025
• CASI Pharmaceuticals Files 6-K, Incorporates Exhibits — 6-K · May 16, 2025
• CASI Pharmaceuticals Announces Management Change — 6-K · May 14, 2025
• CASI Pharmaceuticals Files May 2025 6-K Report — 6-K · May 12, 2025
• CASI Pharmaceuticals Files 6-K Report — 6-K · May 7, 2025
• CASI Pharma ends NY litigation, demands arbitration vs Acrotech — 6-K · Apr 9, 2025
• CASI Pharmaceuticals Files April 2025 6-K Report — 6-K · Apr 3, 2025
• CASI Pharmaceuticals Files March 2025 Report — 6-K · Mar 31, 2025
• CASI Pharmaceuticals Files 2024 Annual Report — 20-F · Mar 31, 2025
• CASI Pharma Gets Interim Relief in Juventas Dispute — 6-K · Feb 10, 2025
• CASI Pharmaceuticals Faces Asset Freeze in China — 6-K · Jan 21, 2025